@article{0e6e713b695541b88ef8f3c57c706b0a,
title = "Fast and robust multi-atlas segmentation of brain magnetic resonance images",
abstract = "We introduce an optimised pipeline for multi-atlas brain MRI segmentation. Both accuracy and speed of segmentation are considered. We study different similarity measures used in non-rigid registration. We show that intensity differences for intensity normalised images can be used instead of standard normalised mutual information in registration without compromising the accuracy but leading to threefold decrease in the computation time. We study and validate also different methods for atlas selection. Finally, we propose two new approaches for combining multi-atlas segmentation and intensity modelling based on segmentation using expectation maximisation (EM) and optimisation via graph cuts. The segmentation pipeline is evaluated with two data cohorts: IBSR data (N = 18, six subcortial structures: thalamus, caudate, putamen, pallidum, hippocampus, amygdala) and ADNI data (N = 60, hippocampus). The average similarity index between automatically and manually generated volumes was 0.849 (IBSR, six subcortical structures) and 0.880 (ADNI, hippocampus). The correlation coefficient for hippocampal volumes was 0.95 with the ADNI data. The computation time using a standard multicore PC computer was about 3-4 min. Our results compare favourably with other recently published results.",
keywords = "Atlases, Hippocampus, MRI, Registration, Segmentation",
author = "L{\"o}tj{\"o}nen, {Jyrki MP} and Robin Wolz and Koikkalainen, {Juha R.} and Lennart Thurfjell and Gunhild Waldemar and Hilkka Soininen and Daniel Rueckert",
note = "Funding Information: The Foundation for the National Institutes of Health ( www.fnih.org ) coordinates the private sector participation of the $60 million ADNI public–private partnership that was begun by the National Institute on Aging (NIA) and supported by the National Institutes of Health. To date, more than $27 million has been provided to the Foundation for NIH by Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Merck and Co., Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche, Schering-Plough, Synarc Inc., and Wyeth, as well as non-profit partners the Alzheimer's Association and the Institute for the Study of Aging. Funding Information: This work was partially funded under the 7th Framework Programme by the European Commission ( http.//cordis.europa.eu/ist ; EU-Grant-224328-PredictAD; Name: From Patient Data to Personalised Healthcare in Alzheimer's Disease) and Tekes–Finnish Funding Agency for Technology and Innovation ( www.tekes.fi ; Name: Extraction of diagnostic information from medical images). ",
year = "2010",
month = feb,
day = "1",
doi = "10.1016/j.neuroimage.2009.10.026",
language = "English",
volume = "49",
pages = "2352--2365",
journal = "NeuroImage",
issn = "1053-8119",
publisher = "Academic Press Inc.",
number = "3",
}